Abstract
Down syndrome is a disorder caused by an imbalance in the 21 chromosome, affecting learning and memorizing abilities, which was shown to be improved with memantine administration. In this study we intent to determine the most relevant proteins that could play a role in learning ability, suitable for possible biomarkers and to evaluate the accuracy of several bioinformatic models as a predictive tool. Five different supervised learning models (K-NN, DT, SVM, NB, NN) were applied to the original database and the newly created ones from eight attribute weighting models. Model accuracies were calculated through cross validation. Nine proteins revealed to be strong candidates as future biomarkers and K-NN and Neural Network had the better overall performances and highest accuracies (86.26% ± 0.23%; 81.51% ± 0.48%), which makes them a promising predictive tool to study protein profiles in DS patients’ follow-up after treatment with memantine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
GmbH R. Support Vector Machine - RapidMiner Documentation 2017.
- 2.
GmbH R. Decision Tree - RapidMiner Documentation 2017.
- 3.
GmbH R. Naive Bayes - RapidMiner Documentation 2017.
- 4.
GmbH R. k-NN - RapidMiner Documentation 2017.
- 5.
GmbH R. Neural Net - RapidMiner Documentation 2017.
References
Higuera, C., Gardiner, K.J., Cios, K.J.: Self-organizing feature maps identify proteins critical to learning in a mouse model of Down syndrome. PLoS One 10(6), e0129126 (2015)
Kazemi, M., Salehi, M., Kheirolahi, M.: Down syndrome: current status, challenges and future perspectives. Int. J. Mol. Cell. Med. (IJMCM) 5(3), 125–133 (2016)
Ahmed, M.M., Dhanasekaran, A.R., Block, A., Tong, S., Costa, A.C., Stasko, M., Gardiner, K.J.: Protein dynamics associated with failed and rescued learning in the Ts65Dn mouse model of Down syndrome. PLoS One 10(3), e0119491 (2015)
Gardiner, K.J.: Molecular basis of pharmacotherapies for cognition in Down syndrome. Trends Pharmacol. Sci. 31(2), 66–73 (2010)
Asim, A., Kumar, A., Muthuswamy, S., Jain, S., Agarwal, S.: Down syndrome: an insight of the disease. J. Biomed. Sci. 22(1), 41 (2015)
Hosseinzadeh, F., KayvanJoo, A.H., Ebrahimi, M., Goliaei, B.: Prediction of lung tumor types based on protein attributes by machine learning algorithms. Springerplus 2, 238 (2013)
Feng, B., Hoskins, W., Zhou, J., Xu, X., Tang, J.: Using supervised machine learning algorithms to screen Down syndrome and identify the critical protein factors. In: Xhafa, F., Patnaik, S., Zomaya, A. (eds.) Advances in Intelligent Systems and Interactive Applications, vol. 686, pp. 302–308. Springer, Cham (2018)
Saraydemir, S., Taşpınar, N., Eroğul, O., Kayserili, H., Dinçkan, N.: Down syndrome diagnosis based on gabor wavelet transform. J. Med. Syst. 36(5), 3205–3213 (2012)
Zhao, Q., Rosenbaum, K., Okada, K., Zand, D.J., Sze, R., Summar, M., Linguraru, M.G.: Automated Down syndrome detection using facial photographs. In: 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) (2013)
Nguyen, C.D., Costa, A.C., Cios, K.J., Gardiner, K.J.: Machine learning methods predict locomotor response to MK-801 in mouse models of Down syndrome. J. Neurogenet. 25(1–2), 40–51 (2011)
Rueda, N., Llorens-Martin, M., Florez, J., Valdizan, E., Banerjee, P., Trejo, J.L., Martinez-Cue, C.: Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome. J. Alzheimer’s Dis. 21(1), 277–290 (2010)
Scott-McKean, J.J., Costa, A.C.: Exaggerated NMDA mediated LTD in a mouse model of Down syndrome and pharmacological rescuing by memantine. Learn Mem. 18(12), 774–778 (2011)
Lockrow, J., Boger, H., Bimonte-Nelson, H., Granholm, A.C.: Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome. Behav. Brain Res. 221(2), 610–622 (2011)
Victorino, D.B., Bederman, I.R., Costa, A.C.S.: Pharmacokinetic properties of memantine after a single intraperitoneal administration and multiple oral doses in euploid mice and in the Ts65Dn mouse model of Down’s syndrome. Basic Clin. Pharmacol. Toxicol. 121(5), 382–389 (2017)
Herault, Y., Delabar, J.M., Fisher, E.M.C., Tybulewicz, V.L.J., Yu, E., Brault, V.: Rodent models in Down syndrome research: impact and future opportunities, 1 October 2017
Costa, A.C.: On the promise of pharmacotherapies targeted at cognitive and neurodegenerative components of Down syndrome. Dev. Neurosci. 33(5), 414–427 (2011)
Xing, Z., Li, Y., Pao, A., Bennett, A.S., Tycko, B., Mobley, W.C., Yu, Y.E.: Mouse-based genetic modeling and analysis of Down syndrome. Br. Med. Bull. 120(1), 111–122 (2017)
Down Syndrome Memantine Follow-up Study - Full Text View - ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02304302
Higuera, C., Gardiner, K.J., Cios, K.J.: Mice protein expression data set. UCI MLRep (2015)
Hosseinzadeh, F., Ebrahimi, M., Goliaei, B., Shamabadi, N.: Classification of lung cancer tumors based on structural and physicochemical properties of proteins by bioinformatics models. PLoS One 7(7), e40017 (2012)
Cowley, P.M., Nair, D.R., DeRuisseau, L.R., Keslacy, S., Atalay, M., DeRuisseau, K.C.: Oxidant production and SOD1 protein expression in single skeletal myofibers from Down syndrome mice. Redox Biol. 13, 421–425 (2017)
Schupf, N., Lee, A., Park, N., Dang, L.H., et al.: Candidate genes for Alzheimer’s disease are associated with individual differences in plasma levels of beta amyloid peptides in adults with Down syndrome. Neuro Aging 36(10), 2907.e1–2907.e10 (2015)
Bustos, F.J., Jury, N., Martinez, P., Ampuero, E., Campos, M., Abarzua, S., Jaramillo, K., Ibing, S., Mardones, M.D., Haensgen, H., Kzhyshkowska, J., Tevy, M.F., Neve, R., Sanhueza, M., Varela-Nallar, L., Montecino, M., van Zundert, B.: NMDA receptor subunit composition controls dendritogenesis of hippocampal neurons through CAMKII, CREB-P, and H3K27ac. J. Cell. Physiol. 232(12), 3677–3692 (2017)
Acknowledgments
This study was funded by QVida+: Estimação Contínua de Qualidade de Vida para Auxílio Eficaz à Decisão Clínica, NORTE‐01‐0247‐FEDER‐003446, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF) and strategic project LIACC (PEst-UID/CEC/00027/2013).
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this paper
Cite this paper
Ribeiro-Machado, C., Silva, S.C., Aguiar, S., Faria, B.M. (2018). Protein Attributes-Based Predictive Tool in a Down Syndrome Mouse Model: A Machine Learning Approach. In: Rocha, Á., Adeli, H., Reis, L., Costanzo, S. (eds) Trends and Advances in Information Systems and Technologies. WorldCIST'18 2018. Advances in Intelligent Systems and Computing, vol 747. Springer, Cham. https://doi.org/10.1007/978-3-319-77700-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-77700-9_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-77699-6
Online ISBN: 978-3-319-77700-9
eBook Packages: EngineeringEngineering (R0)